Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice

Published:2014-03 Issue:2 Volume:3 Page:147-155
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Freedman Mark S.,Comi Giancarlo,De Stefano Nicola,Barkhof Frederik,Polman Chris H.,Uitdehaag Bernard M.J.,Lehr Lorenz,Stubinski Bettina,Kappos Ludwig

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference37 articles.

1. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a;Barkhof;Annals of Neurology,2003

2. Intramuscular interferon beta-1a therapy in patients with relapsing–remitting multiple sclerosis: a 15-year follow-up study;Bermel;Multiple Sclerosis Journal,2010

3. Axonal degeneration and progressive neurologic disability in multiple sclerosis;Bjartmar;Neurotoxicity Research,2003

4. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage;Bruck;Journal of Neurology,2005

5. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta;Comi;Clinical Therapeutics,2009

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis;Neurologic Clinics;2024-02

2. A Blood Test for the Diagnosis of Multiple Sclerosis;International Journal of Molecular Sciences;2024-01-30

3. Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation;Expert Review of Clinical Immunology;2023-09-11

4. Neural stem cell engineering for the treatment of multiple sclerosis;Biomedical Engineering Advances;2022-12

5. An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis;Current Neurology and Neuroscience Reports;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3